| Id: | acc2517 |
| Group: | 1sens |
| Protein: | stathmin |
| Gene Symbol: | STMN1 |
| Protein Id: | P16949 |
| Protein Name: | STMN1_HUMAN |
| PTM: | phosphorylation |
| Site: | Ser38 |
| Site Sequence: | KESVPEFPLSPPKKKDLSLEE |
| Disease Category: | Cancer |
| Disease: | Ovarian Cancer |
| Disease Subtype: | clear cell carcinoma |
| Disease Cellline: | RMG-1 |
| Disease Info: | |
| Drug: | paclitaxel |
| Drug Info: | "Paclitaxel is a plant-derived alkaloid and potent antineoplastic agent that stabilizes microtubules to inhibit cancer cell division, primarily used in the treatment of ovarian, breast, and lung cancers. " |
| Effect: | reduce |
| Effect Info: | "Eribulin-induced stathmin phosphorylation is partially mediated by PP2A downregulation, which reduces the activity of stathmin and enhances the antiproliferative effect of paclitaxel on ovarian cancer." |
| Note: | site unclear |
| Score: | 5.0 |
| Pubmed(PMID): | 36328498 |
| Sentence Index: | 36328498_9 |
| Sentence: | "These results suggest that eribulin-induced phosphorylation of stathmin, mediated in part by PP2A downregulation, reduces stathmin activity and enhances the antiproliferative effects of paclitaxel in ovarian cancer." |
Sequence & Structure:
MASSDIQVKELEKRASGQAFELILSPRSKESVPEFPLSPPKKKDLSLEEIQKKLEAAEERRKSHEAEVLKQLAEKREHEKEVLQKAIEENNNFSKMAEEKLTHKMEANKENREAQMAAKLERLREKDKHIEEVRKNKESKDPADETEAD
No data.
No data.
Protein Tractability:
source: Open TargetsPTM Intensity:
source: CPTAC| STMN1-Ser38 | |
|---|---|
| Cancer | Intensity |
| BRCA | -1.168 |
| COAD | 1.155 |
| HGSC | -0.587 |
| ccRCC | 0.172 |
| GBM | -1.894 |
| HNSC | 0.771 |
| LUAD | 0.51 |
| LUSC | 0.588 |
| non_ccRCC | -1.017 |
| PDAC | 0.853 |
| UCEC | 0.617 |
PTM-Disease Association:
source: PTMD| Residue | Position | State | Disease | Class | PMID |
|---|---|---|---|---|---|
| S | 38 | D | Fanconi anemia | Phosphorylation | 26466335 |
| S | 38 | D | Alzheimer's disease | Phosphorylation | 16925597 |
| S | 38 | P | Endometrial cancer/carcinoma | Phosphorylation | 23538402 |
| S | 38 | U | Breast cancer | Phosphorylation | 26087399 ; 27130664 |
| S | 38 | U | Schizophrenia | Phosphorylation | 16925597 |
State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.
PTM-Drug Perturbation Response:
source: DecryptM| Protein | Gene | PTM | Position | Modified sequence | Cell | Drug | pEC50 | Regulation | Experiment |
|---|---|---|---|---|---|---|---|---|---|
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | RPMI8226 | BTZ | 8.3711 | up | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | RPMI8226 | BTZ | 8.267 | up | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 7.5742 | up | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 7.5609 | up | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 6.9543 | up | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | RPMI8226 | BTZ | 7.4166 | up | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | RPMI8226 | BTZ | 7.257 | up | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 8.6677 | up | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 7.9297 | up | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | RPMI8226 | BTZ | 7.7605 | up | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | RPMI8226 | BTZ | 7.7221 | up | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 6.9176 | up | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 6.1302 | up | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -3.0295 | up | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | A431 | Afatinib | 8.5847 | down | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | A549 | Staursporin | 6.2619 | down | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | Staursporin | 6.2115 | down | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | Staursporin | 6.1754 | down | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | BT-474 | Lapatinib | 6.9895 | down | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | BT-474 | Lapatinib | 6.8899 | down | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | HeLa | CUDC101 | 4.3434 | down | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | PC-9 | Lapatinib | 4.69 | down | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 8.1883 | down | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 7.6554 | down | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 7.6547 | down | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Afatinib | 8.7353 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Afatinib | 8.2921 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A431 | Afatinib | 6.7609 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Afatinib | 9.0483 | - | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | A431 | Afatinib | 8.9141 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Afatinib | 5.4488 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A431 | Afatinib | 2 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Afatinib | 8.9405 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Afatinib | 6.2203 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Afatinib | 7.8143 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Afatinib | 7.5188 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Dasatinib | 11.7841 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Dasatinib | 10.4952 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A431 | Dasatinib | 9.4703 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A431 | Dasatinib | 8.9977 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Dasatinib | 8.9186 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | A431 | Dasatinib | 8.8578 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Dasatinib | 6.5808 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A431 | Dasatinib | 9.9492 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Dasatinib | 9.9403 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Dasatinib | 9.926 | - | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | A431 | Dasatinib | 5.4336 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Dasatinib | 10.0213 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Dasatinib | 7.242 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Dasatinib | 10.2396 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Dasatinib | 8.5058 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Gefitinib | 7.265 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Gefitinib | 6.7746 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Gefitinib | 9.9943 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Gefitinib | 8.0103 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A431 | Gefitinib | 8.703 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Gefitinib | 8.4461 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Gefitinib | 8.0046 | - | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | A431 | Gefitinib | 6.2624 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Gefitinib | 13.9591 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Gefitinib | 7.1704 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A431 | Imatinib | 9.425 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A431 | Imatinib | 8.9912 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A431 | Imatinib | 2 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | A549 | AZD8055 | 10.7135 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | AZD8055 | 10.5831 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A549 | AZD8055 | 9.8617 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | AZD8055 | 7.2917 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A549 | AZD8055 | 5.1808 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A549 | Dactolisib | 15 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | Dactolisib | 7.2704 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A549 | Dactolisib | 6.2619 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | Dactolisib | 6.0781 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | Dactolisib | 5.8436 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | A549 | Dactolisib | 2 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | Dasatinib | 10.6043 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A549 | Dasatinib | 8.9728 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | Dasatinib | 8.3916 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | Dasatinib | 8.2435 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | Dasatinib | 7.0189 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | Dasatinib | 5.6202 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | Dasatinib | 4.2844 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | A549 | Dasatinib | 2 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A549 | MK2206 | 10.9144 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | MK2206 | 9.4462 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A549 | MK2206 | 7.0347 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | MK2206 | 6.4952 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | MK2206 | 6.3508 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | A549 | Nintedanib | 11.0402 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A549 | Nintedanib | 8.9463 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | Nintedanib | 8.8456 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A549 | Nintedanib | 8.7654 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | Nintedanib | 6.7715 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | Nintedanib | 6.5303 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | PD325901 | 15 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A549 | PD325901 | 11.0136 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A549 | PD325901 | 10.7361 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | PD325901 | 9.1645 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A549 | PD325901 | 8.9997 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | A549 | PD325901 | 7.8696 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | PD325901 | 7.3983 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | PD325901 | 4.4803 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A549 | Pictilisib | 11.1523 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A549 | Pictilisib | 10.8876 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | A549 | Pictilisib | 8.7561 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | Pictilisib | 8.2404 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | Pictilisib | 7.8744 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | Pictilisib | 7.367 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | Refametinib | 9.571 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A549 | Refametinib | 8.765 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | A549 | Refametinib | 8.7163 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | Refametinib | 8.262 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | Refametinib | 2 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A549 | Staursporin | 6.1858 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | Staursporin | 6.0189 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | A549 | Tideglusib | 10.7988 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | A549 | Tideglusib | 9.0165 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | A549 | Tideglusib | 8.8047 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | A549 | Tideglusib | 8.3156 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | A549 | Tideglusib | 5.3595 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | A549 | Tideglusib | 2 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | ARH-77 | Rituximab | 1.3802 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | ARH-77 | Rituximab | 1.1838 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | ARH-77 | Rituximab | 0.0537 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | ARH-77 | Rituximab | -0.2383 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | ARH-77 | Rituximab | -1.2202 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | ARH-77 | Rituximab | -1.2203 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | ARH-77 | Rituximab | -4.1423 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | ARH-77 | Rituximab | 0.9448 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | ARH-77 | Rituximab | -0.03 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | ARH-77 | Rituximab | -0.081 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | ARH-77 | Rituximab | -1.2169 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | ARH-77 | Rituximab | -1.2187 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | ARH-77 | Rituximab | -4.2544 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | ARH-77 | Rituximab | -1.2035 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | ARH-77 | Rituximab | -1.2196 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | ARH-77 | Rituximab | -3.7767 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | ARH-77 | Rituximab | -3.8465 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | ARH-77 | Rituximab | -3.9751 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | ARH-77 | Rituximab | -3.9841 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | ARH-77 | Rituximab | -4.0555 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | ARH-77 | Rituximab | -4.1854 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | ARH-77 | Rituximab | 2.2839 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | ARH-77 | Rituximab | 0.852 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | ARH-77 | Rituximab | 0.0668 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | ARH-77 | Rituximab | 2.2173 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | ARH-77 | Rituximab | 1.6571 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | ARH-77 | Rituximab | -4.4778 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | BT-474 | Lapatinib | 4.4316 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | BT-474 | Pertuzumab | -1.9698 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | BT-474 | Pertuzumab | -2.9853 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | BT-474 | Pertuzumab | -4.2449 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | BT-474 | Pertuzumab | -4.3264 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | BT-474 | Pertuzumab | -6.0267 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | BT-474 | Trastuzumab | -2.569 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | BT-474 | Trastuzumab | -2.71 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | HeLa | A485 | 10.8164 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | HeLa | A485 | 10.4729 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | HeLa | A485 | 10.2088 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | HeLa | A485 | 6.2301 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | HeLa | A485 | 5.2664 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | HeLa | A486 | 14 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | HeLa | A486 | 14 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | HeLa | A486 | 11.1116 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | HeLa | A486 | 5.2393 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | HeLa | CUDC101 | 13.5229 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | HeLa | CUDC101 | 7.187 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | HeLa | CUDC101 | 5.2696 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | HeLa | CUDC101 | 4.6943 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | HeLa | Curcumin | 9.5712 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | HeLa | Curcumin | 7.4504 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | HeLa | Curcumin | 5.5379 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | HeLa | Curcumin | 5.4809 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | HeLa | Romidepsin | 8.4875 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | HeLa | Romidepsin | 8.3082 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | HeLa | SAHA | 5.7602 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | HeLa | SAHA | 2.4332 | - | |
| P16949 | STMN1 | P | Ser28;Ser38 | S(ph)KESVPEFPLS(ph)PPK | K562 | Dasatinib | 9.3588 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | K562 | Dasatinib | 9.2579 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | K562 | Dasatinib | 9.2564 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | K562 | Dasatinib | 9.2492 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.2441 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.239 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.2186 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | K562 | Dasatinib | 9.134 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.123 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | K562 | Dasatinib | 8.2172 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | K562 | Dasatinib | 8.0024 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 7.8319 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 7.7709 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | K562 | Dasatinib | 7.2622 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | K562 | Dasatinib | 6.2727 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | K562 | Dasatinib | 6.2586 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | K562 | Dasatinib | 11.0187 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | K562 | Dasatinib | 10.7753 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | K562 | Dasatinib | 10.6265 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.3226 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.2862 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.2821 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.2784 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | K562 | Dasatinib | 9.2644 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | K562 | Dasatinib | 7.7298 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.7585 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | K562 | Dasatinib | 9.736 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | K562 | Dasatinib | 9.6547 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.5178 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | K562 | Dasatinib | 9.3206 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | K562 | Dasatinib | 9.2649 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | K562 | Dasatinib | 8.9686 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | K562 | Dasatinib | 8.9112 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | K562 | Imatinib | 14.2627 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | K562 | Imatinib | 11.0646 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | K562 | Imatinib | 8.2464 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | K562 | Imatinib | 7.2624 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | K562 | Imatinib | 7.0553 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | K562 | Imatinib | 6.9948 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | KYSE-520 | SHP099 | 8.3986 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | KYSE-520 | SHP099 | 7.0624 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | KYSE-520 | SHP099 | 6.2517 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | KYSE-520 | SHP099 | 6.2494 | - | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | KYSE-520 | SHP099 | 5.4444 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | KYSE-520 | SHP099 | 5.4019 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | KYSE-520 | SHP099 | 5.2785 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | MDA-MB-175 | Lapatinib | 10.0044 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | MDA-MB-175 | Lapatinib | 7.535 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | MDA-MB-175 | Lapatinib | 7.175 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | MDA-MB-175 | Pertuzumab | -1.2201 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | MDA-MB-175 | Pertuzumab | -2.2044 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | MDA-MB-175 | Trastuzumab | 2.1007 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | MDA-MB-175 | Trastuzumab | -2.7378 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | MDA-MB-175 | Trastuzumab | -3.0369 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | PC-9 | AZD4547 | 6.973 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | PC-9 | AZD4547 | 5.265 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | PC-9 | AZD4547 | 5.2589 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | PC-9 | AZD4547 | 5.2551 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | PC-9 | Lapatinib | 7.2417 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | PC-9 | Lapatinib | 5.973 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | PC-9 | Lapatinib | 4.7594 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | PC-9 | Lapatinib | 4.6981 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | PC-9 | LapatinibAZD4547 | 6.7369 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | PC-9 | LapatinibAZD4547 | 6.6114 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | PC-9 | LapatinibAZD4547 | 5.3551 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | PC-9 | LapatinibAZD4547 | 5.2703 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | PC-9 | LapatinibAZD4547 | 5.242 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | Ramos | Rituximab | 5.5229 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | Ramos | Rituximab | 1.7674 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | Ramos | Rituximab | -0.9843 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | Ramos | Rituximab | -1.2958 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | Ramos | Rituximab | -2.8773 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | Ramos | Rituximab | 2.3156 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | Ramos | Rituximab | -1.9534 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | Ramos | Rituximab | -2.4784 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | Ramos | Rituximab | -2.7321 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | Ramos | Rituximab | -3.199 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | Ramos | Rituximab | -3.4239 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | Ramos | Rituximab | -1.3745 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | Ramos | Rituximab | -2.7069 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | Ramos | Rituximab | -2.7267 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | Ramos | Rituximab | -2.7279 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | Ramos | Rituximab | -4.2495 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | Ramos | Rituximab | -2.82 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | Ramos | Rituximab | -2.8235 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | Ramos | Rituximab | -2.8432 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | Ramos | Rituximab | -2.9087 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | Ramos | Rituximab | -0.8097 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | Ramos | Rituximab | -0.9807 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | Ramos | Rituximab | -2.1954 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | Ramos | Rituximab | -2.237 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | Ramos | Rituximab | -2.2391 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | Ramos | Rituximab | -1.7345 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | Ramos | Rituximab | -1.7844 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | Ramos | Rituximab | -2.2799 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | Ramos | Rituximab | -4.2398 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 9.4811 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 8.1033 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 7.5209 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 7.1924 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 6.6348 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 6.5235 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 16 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 12.36 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 12.1683 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 11.9207 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 9.7863 | - | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | RPMI8226 | BTZ | 9.7503 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 7.9091 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 7.6219 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 7.4937 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 7.4627 | - | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | RPMI8226 | BTZ | 6.5745 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 3 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 16 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 12.3619 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 12.1907 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 12.1475 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 10.4616 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 10.1623 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 9.1179 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 8.7524 | - | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | RPMI8226 | BTZ | 8.6179 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 8.4449 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 7.1478 | - | |
| P16949 | STMN1 | P | Ser31;Ser38 | SKES(ph)VPEFPLS(ph)PPK | RPMI8226 | BTZ | 6.4444 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 12.5919 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 12.5554 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 11.8583 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 10.1822 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 7.6687 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 7.4415 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 7.3839 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 7.3576 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 7.2571 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 6.426 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | RPMI8226 | BTZ | 3.9496 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 3.0167 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 16 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 8.8662 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 8.727 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 7.655 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 7.4412 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 7.4028 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | RPMI8226 | BTZ | 7.3445 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | RPMI8226 | BTZ | 4.365 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | SK-BR-3 | Lapatinib | 7.8497 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SK-BR-3 | Lapatinib | 7.2624 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | SK-BR-3 | Lapatinib | 7.22 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SK-BR-3 | Pertuzumab | 3.9073 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | SK-BR-3 | Pertuzumab | 2.1465 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | SK-BR-3 | Pertuzumab | -3.1333 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | SK-BR-3 | Trastuzumab | 2.7008 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKKK | SK-BR-3 | Trastuzumab | -2.2017 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | SK-BR-3 | Trastuzumab | -2.2095 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SK-BR-3 | Trastuzumab | -2.763 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -1.2772 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -1.3286 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | SU-DHL-4 | Rituximab | -1.5016 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | SU-DHL-4 | Rituximab | -1.2707 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | SU-DHL-4 | Rituximab | -1.2807 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -1.3 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -3.0081 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | SU-DHL-4 | Rituximab | 1.0302 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | SU-DHL-4 | Rituximab | -1.5192 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -2.9389 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | SU-DHL-4 | Rituximab | -4.2381 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -3.2268 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | SU-DHL-4 | Rituximab | -1.4405 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | SU-DHL-4 | Rituximab | -3.2574 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -3.5813 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | 1.9546 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | SU-DHL-4 | Rituximab | -1.4519 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -1.4525 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | SU-DHL-4 | Rituximab | -1.5877 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKK | SU-DHL-4 | Rituximab | -1.3791 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPKKK | SU-DHL-4 | Rituximab | -1.4041 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -1.4264 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -1.4383 | - | |
| P16949 | STMN1 | P | Ser38 | SKESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -1.1344 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPKK | SU-DHL-4 | Rituximab | -1.1648 | - | |
| P16949 | STMN1 | P | Ser38 | ESVPEFPLS(ph)PPK | SU-DHL-4 | Rituximab | -1.2242 | - |
pEC50 Note: pEC50 is the negative logarithm of EC50 (half-maximal effective concentration, dosage unit Mol), calculated as pEC50 = -log10(EC50), which quantifies the potency of a drug or compound.
Function score:
source: funscoRNo data.
